These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

282 related items for PubMed ID: 24979556

  • 1. Therapeutic effects, tolerability and safety of a multi-strain probiotic in Iranian adults with irritable bowel syndrome and bloating.
    Jafari E, Vahedi H, Merat S, Momtahen S, Riahi A.
    Arch Iran Med; 2014 Jul; 17(7):466-70. PubMed ID: 24979556
    [Abstract] [Full Text] [Related]

  • 2. A randomized double-blind placebo-controlled clinical trial on efficacy and safety of association of simethicone and Bacillus coagulans (Colinox®) in patients with irritable bowel syndrome.
    Urgesi R, Casale C, Pistelli R, Rapaccini GL, de Vitis I.
    Eur Rev Med Pharmacol Sci; 2014 Jul; 18(9):1344-53. PubMed ID: 24867512
    [Abstract] [Full Text] [Related]

  • 3. Effect of multispecies probiotics on irritable bowel syndrome: a randomized, double-blind, placebo-controlled trial.
    Yoon JS, Sohn W, Lee OY, Lee SP, Lee KN, Jun DW, Lee HL, Yoon BC, Choi HS, Chung WS, Seo JG.
    J Gastroenterol Hepatol; 2014 Jan; 29(1):52-9. PubMed ID: 23829297
    [Abstract] [Full Text] [Related]

  • 4. A randomized controlled trial of a probiotic combination VSL# 3 and placebo in irritable bowel syndrome with bloating.
    Kim HJ, Vazquez Roque MI, Camilleri M, Stephens D, Burton DD, Baxter K, Thomforde G, Zinsmeister AR.
    Neurogastroenterol Motil; 2005 Oct; 17(5):687-96. PubMed ID: 16185307
    [Abstract] [Full Text] [Related]

  • 5. The effect of a multispecies probiotic mixture on the symptoms and fecal microbiota in diarrhea-dominant irritable bowel syndrome: a randomized, double-blind, placebo-controlled trial.
    Ki Cha B, Mun Jung S, Hwan Choi C, Song ID, Woong Lee H, Joon Kim H, Hyuk J, Kyung Chang S, Kim K, Chung WS, Seo JG.
    J Clin Gastroenterol; 2012 Mar; 46(3):220-7. PubMed ID: 22157240
    [Abstract] [Full Text] [Related]

  • 6. Bacillus coagulans significantly improved abdominal pain and bloating in patients with IBS.
    Hun L.
    Postgrad Med; 2009 Mar; 121(2):119-24. PubMed ID: 19332970
    [Abstract] [Full Text] [Related]

  • 7. A double blind randomized controlled trial of a probiotic combination in 100 patients with irritable bowel syndrome.
    Drouault-Holowacz S, Bieuvelet S, Burckel A, Cazaubiel M, Dray X, Marteau P.
    Gastroenterol Clin Biol; 2008 Feb; 32(2):147-52. PubMed ID: 18387426
    [Abstract] [Full Text] [Related]

  • 8. Linaclotide for irritable bowel syndrome with constipation: a 26-week, randomized, double-blind, placebo-controlled trial to evaluate efficacy and safety.
    Chey WD, Lembo AJ, Lavins BJ, Shiff SJ, Kurtz CB, Currie MG, MacDougall JE, Jia XD, Shao JZ, Fitch DA, Baird MJ, Schneier HA, Johnston JM.
    Am J Gastroenterol; 2012 Nov; 107(11):1702-12. PubMed ID: 22986437
    [Abstract] [Full Text] [Related]

  • 9. Randomized clinical trial on the effect of a multispecies probiotic on visceroperception in hypersensitive IBS patients.
    Ludidi S, Jonkers DM, Koning CJ, Kruimel JW, Mulder L, van der Vaart IB, Conchillo JM, Masclee AA.
    Neurogastroenterol Motil; 2014 May; 26(5):705-14. PubMed ID: 24588932
    [Abstract] [Full Text] [Related]

  • 10. [A randomized, double-blind, placebo-controlled, multicenter study to assess the efficacy and safety of tegaserod in Chinese patients with constipation-predominant irritable bowel syndrome].
    Tegaserod Clinical Research Group.
    Zhonghua Nei Ke Za Zhi; 2003 Feb; 42(2):88-90. PubMed ID: 12783702
    [Abstract] [Full Text] [Related]

  • 11. A randomized clinical trial of Saccharomyces cerevisiae versus placebo in the irritable bowel syndrome.
    Pineton de Chambrun G, Neut C, Chau A, Cazaubiel M, Pelerin F, Justen P, Desreumaux P.
    Dig Liver Dis; 2015 Feb; 47(2):119-24. PubMed ID: 25488056
    [Abstract] [Full Text] [Related]

  • 12. VSL#3 improves symptoms in children with irritable bowel syndrome: a multicenter, randomized, placebo-controlled, double-blind, crossover study.
    Guandalini S, Magazzù G, Chiaro A, La Balestra V, Di Nardo G, Gopalan S, Sibal A, Romano C, Canani RB, Lionetti P, Setty M.
    J Pediatr Gastroenterol Nutr; 2010 Jul; 51(1):24-30. PubMed ID: 20453678
    [Abstract] [Full Text] [Related]

  • 13. Randomised clinical trial: the safety and efficacy of AST-120 in non-constipating irritable bowel syndrome - a double-blind, placebo-controlled study.
    Tack JF, Miner PB, Fischer L, Harris MS.
    Aliment Pharmacol Ther; 2011 Oct; 34(8):868-77. PubMed ID: 21883322
    [Abstract] [Full Text] [Related]

  • 14. Clinical trial: multispecies probiotic supplementation alleviates the symptoms of irritable bowel syndrome and stabilizes intestinal microbiota.
    Kajander K, Myllyluoma E, Rajilić-Stojanović M, Kyrönpalo S, Rasmussen M, Järvenpää S, Zoetendal EG, de Vos WM, Vapaatalo H, Korpela R.
    Aliment Pharmacol Ther; 2008 Jan 01; 27(1):48-57. PubMed ID: 17919270
    [Abstract] [Full Text] [Related]

  • 15. Randomised clinical trial: Bifidobacterium bifidum MIMBb75 significantly alleviates irritable bowel syndrome and improves quality of life--a double-blind, placebo-controlled study.
    Guglielmetti S, Mora D, Gschwender M, Popp K.
    Aliment Pharmacol Ther; 2011 May 01; 33(10):1123-32. PubMed ID: 21418261
    [Abstract] [Full Text] [Related]

  • 16. Clinical studies on alleviating the symptoms of irritable bowel syndrome.
    Kajander K, Korpela R.
    Asia Pac J Clin Nutr; 2006 May 01; 15(4):576-80. PubMed ID: 17077079
    [Abstract] [Full Text] [Related]

  • 17. Randomized clinical trial: effect of Lactobacillus plantarum 299 v on symptoms of irritable bowel syndrome.
    Stevenson C, Blaauw R, Fredericks E, Visser J, Roux S.
    Nutrition; 2014 Oct 01; 30(10):1151-7. PubMed ID: 25194614
    [Abstract] [Full Text] [Related]

  • 18. A double-blind, placebo-controlled, randomized study to evaluate the efficacy, safety and tolerability of tegaserod in patients with irritable bowel syndrome.
    Nyhlin H, Bang C, Elsborg L, Silvennoinen J, Holme I, Rüegg P, Jones J, Wagner A.
    Scand J Gastroenterol; 2004 Feb 01; 39(2):119-26. PubMed ID: 15000272
    [Abstract] [Full Text] [Related]

  • 19. Multi-Center, Double-Blind, Randomized, Placebo-Controlled, Parallel-Group Study to Evaluate the Benefit of the Probiotic Bifidobacterium infantis 35624 in Non-Patients With Symptoms of Abdominal Discomfort and Bloating.
    Ringel-Kulka T, McRorie J, Ringel Y.
    Am J Gastroenterol; 2017 Jan 01; 112(1):145-151. PubMed ID: 27845337
    [Abstract] [Full Text] [Related]

  • 20. Symptomatic efficacy of beidellitic montmorillonite in irritable bowel syndrome: a randomized, controlled trial.
    Ducrotte P, Dapoigny M, Bonaz B, Siproudhis L.
    Aliment Pharmacol Ther; 2005 Feb 15; 21(4):435-44. PubMed ID: 15709995
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 15.